[go: up one dir, main page]

CH439316A - Verfahren zur Herstellung eines neuen Polypeptids - Google Patents

Verfahren zur Herstellung eines neuen Polypeptids

Info

Publication number
CH439316A
CH439316A CH802163A CH802163A CH439316A CH 439316 A CH439316 A CH 439316A CH 802163 A CH802163 A CH 802163A CH 802163 A CH802163 A CH 802163A CH 439316 A CH439316 A CH 439316A
Authority
CH
Switzerland
Prior art keywords
production
new polypeptide
polypeptide
new
Prior art date
Application number
CH802163A
Other languages
English (en)
Inventor
Roger Dr Boissonnas
Stephan Dr Guttmann
Janos Dr Pless
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Priority to CH802163A priority Critical patent/CH439316A/de
Priority to NO153667A priority patent/NO115214B/no
Priority to GB24840/64A priority patent/GB1064263A/en
Priority to NL6407156A priority patent/NL6407156A/xx
Priority to AT550864A priority patent/AT266332B/de
Priority to BE649794A priority patent/BE649794A/xx
Priority to ES0301459A priority patent/ES301459A1/es
Priority to FR979878A priority patent/FR1426916A/fr
Priority to FR989292A priority patent/FR3966M/fr
Priority to OA51499A priority patent/OA01252A/xx
Publication of CH439316A publication Critical patent/CH439316A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695Corticotropin [ACTH]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052Val-amino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
CH802163A 1963-06-28 1963-06-28 Verfahren zur Herstellung eines neuen Polypeptids CH439316A (de)

Priority Applications (10)

Application Number Priority Date Filing Date Title
CH802163A CH439316A (de) 1963-06-28 1963-06-28 Verfahren zur Herstellung eines neuen Polypeptids
NO153667A NO115214B (de) 1963-06-28 1964-06-16
GB24840/64A GB1064263A (en) 1963-06-28 1964-06-16 Improvements in or relating to a pentacosapeptide
NL6407156A NL6407156A (de) 1963-06-28 1964-06-23
AT550864A AT266332B (de) 1963-06-28 1964-06-26 Verfahren zur Herstellung eines neuen Polypeptids
BE649794A BE649794A (de) 1963-06-28 1964-06-26
ES0301459A ES301459A1 (es) 1963-06-28 1964-06-26 Procedimiento para la produccion de polipepturos.
FR979878A FR1426916A (fr) 1963-06-28 1964-06-26 Nouveau polypeptide et sa préparation
FR989292A FR3966M (de) 1963-06-28 1964-09-25
OA51499A OA01252A (fr) 1963-06-28 1964-12-31 Nouveau polypeptide et sa préparation.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH802163A CH439316A (de) 1963-06-28 1963-06-28 Verfahren zur Herstellung eines neuen Polypeptids

Publications (1)

Publication Number Publication Date
CH439316A true CH439316A (de) 1967-07-15

Family

ID=4333925

Family Applications (1)

Application Number Title Priority Date Filing Date
CH802163A CH439316A (de) 1963-06-28 1963-06-28 Verfahren zur Herstellung eines neuen Polypeptids

Country Status (9)

Country Link
AT (1) AT266332B (de)
BE (1) BE649794A (de)
CH (1) CH439316A (de)
ES (1) ES301459A1 (de)
FR (1) FR3966M (de)
GB (1) GB1064263A (de)
NL (1) NL6407156A (de)
NO (1) NO115214B (de)
OA (1) OA01252A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115137809A (zh) * 2021-03-31 2022-10-04 张菁 含有促肾上腺皮质激素及其衍生物的药物及其用途

Also Published As

Publication number Publication date
NO115214B (de) 1968-09-02
GB1064263A (en) 1967-04-05
AT266332B (de) 1968-11-11
BE649794A (de) 1964-12-28
OA01252A (fr) 1969-01-25
FR3966M (de) 1966-02-28
NL6407156A (de) 1964-12-29
ES301459A1 (es) 1965-01-16

Similar Documents

Publication Publication Date Title
AT281312B (de) Verfahren zur Herstellung eines neuen Polypeptids
CH427803A (de) Verfahren zur Herstellung eines neuen Isoxazolderivates
CH447624A (de) Verfahren zur Herstellung eines selbstschmierenden Werkstoffes
AT255667B (de) Verfahren zur Herstellung eines neuen Polypeptids
CH467246A (de) Verfahren zur Herstellung eines neuen Polypeptids
AT251775B (de) Verfahren zur Herstellung eines neuen Polypeptids
AT251208B (de) Verfahren zur Herstellung eines neuen Polypeptids
AT252474B (de) Verfahren zur Herstellung eines neuen Polypeptids
AT258483B (de) Verfahren zur Herstellung eines neuen Polypeptids
AT265538B (de) Verfahren zur Herstellung eines neuen Polypeptids
AT251207B (de) Verfahren zur Herstellung eines neuen Polypeptids
AT251888B (de) Verfahren zur Herstellung eines neuen Polymerisationsproduktes
AT304077B (de) Verfahren zur Herstellung von neuen Esterimidharzen
CH443335A (de) Verfahren zur Herstellung eines neuen Polypeptids
AT267747B (de) Verfahren zur Herstellung von neuen Penicillanylalkoholen
AT266332B (de) Verfahren zur Herstellung eines neuen Polypeptids
AT249068B (de) Verfahren zur Herstellung von neuen Imidazo- und Pyrimido-chinazolinen
AT266335B (de) Verfahren zur Herstellung eines neuen Polypeptids
AT254410B (de) Verfahren zur Herstellung eines neuen Polypeptids
AT254184B (de) Verfahren zur Herstellung von neuen Äthanoanthracenderivaten
CH465608A (de) Verfahren zur Herstellung eines neuen Bis-pyridyl-methyl-disulfids
AT251591B (de) Verfahren zur Herstellung von neuen 4-Nitro-5-hydroxy-pyridazonen-(6)
AT281309B (de) Verfahren zur Herstellung eines neuen Polypeptids
CH465631A (de) Verfahren zur Herstellung eines neuen Polypeptids
AT264495B (de) Verfahren zur Herstellung von neuen basischen Cycloheptanoläthern